PAB
Click for more information
0.00% 0.6¢ patrys limited

running out of ammo?, page-39

  1. Freeway
    4,341 Posts.
    clock Created with Sketch.
    03/12/13
    11:56
    Post #: 12650405
    "In June 2013, Morphosys licensed it's monoclonal antibody MOR202 to Celgene for a $92m upfront payment, $60m milestone payments and double digit royalties. MOR202 is still in Phase 1/2 trials, slightly behind PAB."

    Anything can happen here :)

    There is absolutely no reason why we can't also get a deal NOW.

    IMO
    PAB Price at posting: 5.2¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS A Super PITch is key in the competition for capital
right-arrow Created with Sketch.
NEWS Diggers & Dealers 2024: Kim Beazley ties mining and military together; highlights competition with China in Africa
right-arrow Created with Sketch.
GRX GreenX picks up prospective copper project in Germany
right-arrow Created with Sketch.
NEWS Is oil undervalued?
right-arrow Created with Sketch.
VMT Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth
right-arrow Created with Sketch.
VMS Venture to sniff out high-grade REE targets at Jupiter project, WA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.6¢ 		Change
0.000(0.00%) 		Mkt cap ! $12.34M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $3.1K 516.6K

Buyers (Bids)

No. Vol. Price($)
4 2130203 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 4321304 4
View Market Depth
Last trade - 10.06am 08/08/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.